Clinical Trials in Michigan

Showing 6161-6180 of 16,154 trials

Effects of Open-label Placebos on COVID-related Psychological Health

NCT05035550

This project aimed to test the efficacy of a telehealth-administered placebo without deception intervention on stress, anxiety, and depression related to the COVID-19 pandemic. Participants were randomized into two groups (open-label placebo vs. no-treatment control). All participants received information on the impact of COVID-19 on psychological health. Participants in the open-label placebo group were instructed to watch an informational video on the beneficial effects of placebos without deception, remotely interact with an experimenter, and take open-label placebo pills twice a day for two weeks. Participants in the no-treatment control group did not receive any intervention. Instead, participants met with an experimenter and reported on their psychological and physical health. The investigators predicted that the placebo without deception group would exhibit substantially reduced stress, depression, and anxiety compared to a no-treatment control group.

StressAnxietyDepression

Michigan State University64 participantsStarted Feb 2021

East Lansing, Michigan, United States

COMPLETED53 miles

Chronic Plaque Psoriasis (Ps) Registry

NCT00799877

The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).

Chronic Plaque Psoriasis

AbbVie6,065 participantsStarted Sep 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +336 more locations

Effects of Open-label Placebos on COVID-related Psychological Health

Chronic Plaque Psoriasis (Ps) Registry

Find Trials by Condition in Michigan

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

Prospective SPINE Registry

Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

Integrated Supported Biopsychosocial Self-Management for Back Related Leg Pain

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Effect of Advanced Care at Home vs. Traditional Brick-and-Mortar Hospital Care in Acutely Ill Adults: A Randomized Clinical Trial

A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis